E-MED: La FIP et l'acc�s aux m�dicaments dans les PED
-------------------------------------------------------------------------
[Mod�rateur: Lisa Hayes de Health Action International a envoy� de
communiqu� de presse de la F�d�ration International Pharmaceutique, il y
aura peut-�tre des vagues dans la presse, car les interventions sont
pr�c�d�es d'une conf�rence de presse. Remerciements � Ip-Health. CB]
http://www.cptech.org/ip/health/fip08312002.html
FIP - International Pharmaceutical Federation
World Congress of Pharmacy and Pharmaceutical Sciences
31 August � 5 September 2002, Nice, France
MEDIA ANNOUNCEMENT
International Pharmacists Explore Potential Roles for Improving Access to
Medicines in Developing Countries during Pharmacy Information Symposium at
FIP
Congress in Nice
One-third of the world�s population lacks access to essential medicines.
In the poorest parts of Africa and Asia, this figure rises to one-half. 95%
of TB cases and 98% of TB deaths occur in poor
countries. Worldwide, 79% of people with TB do not have ready access to
treatment. There are 300-500 million new cases of malaria each year, of
which 1-2 million result in death. 95% of the 36 million people with HIV /
AIDS live in developing countries. Research and development into diseases
that affect the poor has stagnated because of the lack of economic
incentives. The last major new TB drug was developed 30 years ago.
Resistance to all infectious disease treatments is on the rise.
The health statistics are frightening and the causes are no less upsetting.
Many developing countries have pharmacy regulatory systems staffed with
well-trained individualsthat are unable to operate due to lack of resources,
corruption or ineffective laws. Some countries are unable to stop the flow
of counterfeit drugs despite possessing the appropriate technical knowledge
and equipment to do so and others do not have the resources to test new
drugs that come on the market to ensure their quality. In many instances,
countries do not have the drug management infrastructure and resources to
effectively and efficiently procure, process, and distribute medicines.
Where systems do exist to ensure delivery of medicines, the lack of
resources often limits the extent to which patients can afford treatment.
The Pharmacy Information Section of the International
PharmaceuticalFederation (FIP) will host �Access and Equity: The challenge
of getting medicines to the people who need them.� during FIP�s
62nd World Congress of Pharmacy and Pharmaceutical Sciences in Nice,France.
The session, organised in collaboration with the World Health Organization�s
Essential Drugs and Medicines Policy programme, will focus on the technical
aspects of access to medicines, for which a pharmacist�s specialty skills
are needed.
A definition of the problem of access and its extent will be discussed,
along with measures needed to address inadequate availability of medicines
in developing countries.
Price and quality are major issues, as is the need to prescribe, distribute,
and use medicines appropriately. The profession�s and FIP�s potential roles
will be discussed and the session will finish with a discussion among
representatives from developing countries about how the pharmacy profession
can contribute to increased access tomedicine for the world�s poor.
As the world�s only international organisation representing the interests of
pharmacy and pharmaceutical sciences, FIP�s role in supporting pharmacy
organisations in developing
countries is evolving. Through its close work with WHO and other health
professions, FIP is working to increase North-South collaboration and
transfer of knowledge and skills. By supporting and strengthening regional
work in the global South, FIP is encouraging the creation of South-South
co-operation, which will eventually lead to sustainable development in the
area of access to medicines.
Journalists are invited to attend the Press Briefing, which will take place
on Wednesday, 4 September 2002, at 10.00am in Room Gallieni 2 at the Nice
Acropolis.
Below are details of Thursday�s symposium:
Session Date/Time: Thursday, 5 September 2002,
9:00 � 12:00
Location: Acropolis, Room Hermes (Level 2)
PRESENTATIONS
Defining the issues: What constitutes access/equity, what impacts our
ability to achieve it,
and how extensive is the problem?
David Lee, Management Sciences for Health (MSH), Panama and USA
The contribution of the essential drugs concept to improved access Hans
Hogerzeil, World Health Organization (WHO/EDM), Switzerland
Neglected diseases and the impact of prices, pricing and patents
Raffaella Ravinetto, M�decins Sans Fronti�res (MSF), Switzerland
Ensuring drug products that are of acceptable quality
Lembit R�go, World Health Organization (WHO/EDM), Switzerland
Drug donations: Can they contribute to improved access?
Serge Barbereau, R�seau M�dicaments et D�veloppement (ReMeD), France
The profession's response: What can pharmacy and FIP do to help resolve the
problem?
John Bell, Commonwealth Pharmaceutical Association (CPA), Australia
Panel discussion: Response from the field
Developing country representatives
For more information contact:
Satu Siiskonen, FIP Project Coordinator
Tel: +33 49 39 28 422 in Nice, France until 5 September
Tel.: +31 70 302 1970 in The Hague
Fax: +31 70 302 1999
E-mail: fip@fip.org
Website http://www.fip.org
--
Adresse pour les messages destin�s au forum E-MED:
<e-med@usa.healthnet.org>
Pour r�pondre � un message envoyer la r�ponse au forum
ou directement � l'auteur.
Pour toutes autres questions addresser vos messages � :
<e-med-help@usa.healthnet.org>